Xuantai Pharmaceuticals: Injectable Isavuconazole and Enzalutamide Tablets are expected to be selected in the twelfth batch of the national drug centralized procurement.

Xuantai Pharmaceutical announced that the company participated in the bidding for the 12th National Centralized Procurement of Drugs. According to the results announcement released by the Joint Procurement Office on July 31, 2026, the company's products, injectable isavuconazole and the co-developed product enzalutamide tablets, are proposed to be selected for this centralized procurement. The procurement period will last from the date of execution of the selected results until December 31, 2029.